Display Settings:

Format

Send to:

Choose Destination
    Ann N Y Acad Sci. 1991;640:276-9.

    Effect of citalopram, a selective 5-HT reuptake blocker, in emotionally disturbed patients with dementia.

    Source

    Department of Psychiatry and Neurochemistry, University of Göteborg, Hisings Backa, Sweden.

    Abstract

    In patients with Alzheimer's disease and vascular dementia, there are symptoms not only of cognitive impairment but also of emotional disturbance. Postmortem human brain studies have shown a disturbed metabolism of serotonin and overactivity of neuroendocrine-controlling factors in the hypothalamus. Treatment with a selective 5-HT reuptake blocker, citalopram, causes a significant reduction in postdexamethasone cortisol levels. Citalopram in patients with dementia disorders produces no improvement in psychomotor and cognitive behavior, but symptoms of emotional disturbance are reduced. Citalopram does not have a pure antidepressant effect; rather, the drug is considered an emotional stabilizer.

    PMID:
    1776751
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for Blackwell Publishing

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk